Drawing for PCOR

USPTO serial 78319416

PCOR

Reviewed by CopyMark Law Group

Reg. 3108607Status 710
Filing date
Status date
Registration date
Jun 27, 2006
Examiner
OSLICK, SCOTT
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PCOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB666 3RD AVE 10TH FLNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and in sciences, namely, plasmidsSECTION 8 - CANCELLED—
005Pharmaceutical and veterinary preparations designed to treat and prevent pathological conditions, namely, genetic diseases, cancers, angiogenesis-related diseases, vascular diseases such as peripheral arterial diseases, critical limb ischemia and intermittent claudication, cardiovascular diseases, coagulation disorders, blood disorders, hemoglobinopathies, inflammatory diseases, infectious diseases, neurologic diseases, neurodegenerative diseases, neuromuscular disorder, myopathies, lysosomal disorders, metabolic diseases, immunodeficiencies, immunological disorders and respiratory diseases; sanitary preparations for medical purposes; chemical preparations for medical and pharmaceutical purposes, namely, plasmid preparations, recombinant plasmid preparations, plasmid-based vaccine preparations, plasmid-based gene therapy preparations, all for gene therapy, for vaccination, for production of therapeutic proteins, in the treatment and prevention of pathological conditions, namely, genetic diseases, cancers, angiogenesis-related diseases, vascular diseases, cardiovascular diseases, coagulation disorders, blood disorders, hemoglobinopathies, inflammatory diseases, infectious diseases, neurologic diseases, neurodegenerative diseases, neuromuscular disorders, myopathies, lysosomal disorders, metabolic diseases, immunodeficienceies, immunological disorders and respiratory diseasesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 1, 2013C8..CANCELLED SEC. 8 (6-YR)—
Dec 9, 2010ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 25, 2006CORVREVIEW OF CORRESPONDENCE COMPLETE—
Aug 21, 2006MAILPAPER RECEIVED—
Jun 27, 2006EXPTEXPARTE APPEAL TERMINATED—
Jun 27, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2006NPUBNOTICE OF PUBLICATION—
Feb 15, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 10, 2006ALIEASSIGNED TO LIE—
Feb 7, 2006MAILPAPER RECEIVED—
Jan 30, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 17, 2005PETGPETITION TO REVIVE-GRANTED—
Nov 17, 2005PETGPETITION TO REVIVE-GRANTED—
Nov 8, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2005MAILPAPER RECEIVED—
Nov 7, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2005PETRPETITION TO REVIVE-RECEIVED—
Nov 1, 2005XAECEXAMINER'S AMENDMENT ENTERED—
Oct 31, 2005CNEAEXAMINERS AMENDMENT MAILED—
Oct 31, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 28, 2005JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Oct 27, 2005EXFBEXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF—
Aug 22, 2005ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Jul 28, 2005PETRPETITION TO REVIVE-RECEIVED—
Jul 28, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2005RECGACTION GRANTING REQ. FOR RECON. MAILED—
Jun 17, 2005CNCFACTION CONTINUING FINAL - COMPLETED—
Jun 6, 2005ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Jun 1, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2005EXPIEX PARTE APPEAL-INSTITUTED—
Jun 1, 2005JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jun 1, 2005EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Dec 3, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 2, 2004CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 17, 2004CNCFCONTINUATION OF FINAL REFUSAL MAILED—
Nov 16, 2004CNCFACTION CONTINUING A FINAL - COMPLETED—
Oct 25, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 12, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 12, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 20, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 2004MAILPAPER RECEIVED—
Apr 23, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2004DOCKASSIGNED TO EXAMINER—
Nov 21, 2003NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance